LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Se
 | Thurs, September 18, 2025 at 8:45 AM |
BALLERUP, Denmark, September 18, 2025--LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)
via: https://finance.yahoo.com/news/leo-pharma-presents-breaking-phase-134500883.html
Share on FacebookComments
